Status:
NOT_YET_RECRUITING
Intervention to Reduce Implicit Bias in Pharmacies
Lead Sponsor:
Massachusetts General Hospital
Conditions:
Bias, Implicit
HIV
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
This study will follow the ADAPT-ITT model to apply the Prejudice Habit Breaking Intervention (PHBI) to pharmacists who have experience with or are willing to prescribe PrEP. We will first collect qua...
Detailed Description
People of color (POC) accounted for nearly 70% of HIV new cases in the US in 2020, compared to 26% of new infections occurring among White individuals. Significant further racial disparities exist in ...
Eligibility Criteria
Inclusion
- Three types of participants will be included
- Pharmacy interns:
- Pharmacy intern (non-licensed individual undergoing training and preparations for licensure examination).
- Currently registered as a regular student in the School of Pharmacy, Bouvé College of Health Sciences at Northeastern University, Boston, MA.
- Doing the internship in pharmacies located in cities with the highest average annual rate of HIV infection diagnosis in Suffolk County, MA.
- Experience with PrEP (counsel PrEP candidates, complete PrEP continuing education activity, or awareness with current CDC guidelines on PrEP use) OR willingness to prescribe PrEP in the future (will be measured with one Yes/No question: "Are you willing to prescribe PrEP in the future?)
- Moderate to high preference for White people as measured by the Implicit Association Test.
- Pharmacy managers
- Defined as an individual designated by a pharmacy owner to manage a pharmacy.
- Pharmacy managers of pharmacies located in the same areas described above.
- Pharmacy policymaker defined as official employee of the Boards of Registration in Pharmacy whose role is directly related to community pharmacy practice (e.g., director of pharmacy compliance).
Exclusion
- Inability to provide consent (e.g., intoxication), unwillingness to provide consent
Key Trial Info
Start Date :
July 1 2027
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2029
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT06487351
Start Date
July 1 2027
End Date
July 1 2029
Last Update
November 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114